C-Rad AB (publ) (STO:CRAD.B)
36.00
+0.30 (0.84%)
At close: Jun 12, 2026
C-Rad AB Market Cap
C-Rad AB has a market cap or net worth of 1.22 billion as of June 12, 2026. Its market cap has increased by 9.70% in one year.
Market Cap
1.22B
Enterprise Value
1.09B
Revenue
427.80M
Ranking
n/a
PE Ratio
40.88
Stock Price
36.00
Market Cap Chart
Since July 23, 2007, C-Rad AB's market cap has increased from 65.86M to 1.22B, an increase of 1,745.62%. That is a compound annual growth rate of 16.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.22B | 13.31% |
| Dec 30, 2025 | 1.07B | 6.50% |
| Dec 30, 2024 | 1.01B | -29.12% |
| Dec 29, 2023 | 1.42B | 10.47% |
| Dec 30, 2022 | 1.29B | -31.57% |
| Dec 30, 2021 | 1.88B | 15.88% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.30B |
| Devyser Diagnostics AB | 1.51B |
| Paxman AB | 1.19B |
| BICO Group AB | 1.15B |
| Sedana Medical AB | 861.25M |
| Senzime AB | 674.45M |
| Bactiguard Holding AB | 555.45M |
| SciBase Holding AB | 511.26M |